Serum Free Market to be dominated by Rise in Biopharmaceutical Industries through 2027
Growing R&D for development of novel therapeutic drugs to drive
the serum free market in the forecast period, 2023-2027.
According to TechSci Research report, “Serum
Free Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2017-2027”, the global serum free market is anticipated to grow
at a significant rate in the forecast period, 2023-2027. The rising incidence
of infectious and chronic diseases, demand for cell therapies for cancer
treatment, and extensive research and development are the primary factors
driving the demand for the global serum free market. Growing adoption of
advanced technology, increasing demand for various recombinant proteins and
types of culture, easier downstream processing, growing research &
development for development of novel therapeutic drugs, expansion of
biopharmaceutical industries and biopharma production, and heavy investments in
healthcare sector are expected to influence the market demand. Also, increasing
strategic growth is also a key factor for increasing the growth of the serum
free market, globally.
However, the requirement of diverse cell-type for
specific media formulation, and low growth rate in comparison to serum-supplemented
media may hamper the growth of the global Serum Free market.
Browse over XX market
data Figures spread through 110 Pages and an in-depth TOC on "Serum Free Market"
The global serum free market
is segmented into media type, end user and company.
Based on media type, the
market is segmented into common serum free, xeno-free, chemically defined,
protein-free, and others. The xeno-free segment is expected to hold the largest
market share. This is attributed to the potential for safe use for human
clinical treatment.
Based on end user, the market
is divided into biotechnology & pharmaceutical companies, academic &
research organizations, contract research organizations, and others. The biotechnology
& pharmaceutical companies segment is anticipated to grow during the
forecast period. This is attributed to rising focus on biopharmaceuticals to
treat chronic diseases, high productivity, and rising drug discovery and
development.
Major operating companies
operating in global serum free market are:
- Corning Incorporated
- Lonza Group AG
- Merck KgaA
- Sartorius AG
- Thermo Fisher Scientific Inc.
- FUJIFILM Holdings Corporation
- PromoCell GmbH
- Athena Environmental Sciences, Inc.
- STEMCELL Technologies Inc.
- Danaher Corporation
- R&D Systems, Inc.
- Sino Biological, Inc.
- HiMedia Laboratories, LLC
- PAN-Biotech GmbH
- MP Biomedicals, LLC
Download Free Sample Report
Customers can also
request for 10% free customization on this report.
“North America region dominates the
market in 2021 and is expected to maintain its dominance in the coming years
due to the presence of many biopharmaceutical companies in the region. Increase
in the research funding for cell and stem cell-based products, presence of a large number of leading
players, strongly established research infrastructure, extensive advancements
in technology, and the growing demand for serum-free media in the region is
another key factor. Also, the high
number of firms with a strategic pipeline for serum-free media in the region are
expected to propel the global serum free market growth till 2027” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“Serum Free Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented
By Media Type (Common Serum Free, Xeno-Free,
Chemically Defined, Protein-Free, Others), By End User (Biotechnology &
Pharmaceutical Companies, Academic & Research Organizations, Contract
Research Organizations, Others), By company and By Region”, has evaluated the future growth potential of global serum
free market and provides statistics & information on market size, structure,
and future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in global serum free market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com